Marketplace Tech

The legacy of the Theranos debacle weighs especially heavy on women in biotech

08.27.2021 - By MarketplacePlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

The trial of Elizabeth Holmes, former CEO and founder of the blood test company Theranos, is set to begin next week. Holmes is charged with wire fraud, having allegedly defrauded investors about the accuracy of Theranos’ technology. She’s pleaded not guilty. Many other women founders — especially in biotech and health care — have been getting compared to Holmes. Marketplace’s Jed Kim speaks with Erin Griffith, a reporter who covers startups and venture capital for The New York Times. Griffith says investors often ask female entrepreneurs to prove they’re not another Theranos.

More episodes from Marketplace Tech